MedPath

Comparative Clinical Performance of 59% Hioxifilcon A Contact Lenses vs. Marketed Hydrogel Contact Lenses

Not Applicable
Completed
Conditions
Refractive Error - Myopia Bilateral
Registration Number
NCT04671108
Lead Sponsor
Vision Service Plan
Brief Summary

The study will compare the short-term clinical performance and wearer and practitioner acceptability of a new-to-market spherical daily disposable (DD) hydrogel soft contact lens to a currently marketed spherical DD hydrogel soft contact lens.

Detailed Description

This randomized clinical trial will compare the short-term clinical performance, and wearer acceptability of a new-to-market hioxifilcon A spherical daily DD contact lenses against marketed DD lenses in a short cross-over clinical trial.

The primary outcome variable for this study is overall subjective comfort.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Currently wearing spherical DD contact lenses at least 5 days/week
  • Vision correctable to 20/30 acuity in each eye with spherical DD contact lenses
  • No ocular or systemic disease that contra-indicates soft contact lens wear
Exclusion Criteria
  • Participating in another clinical trial
  • Vision not correctable to 20/30

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Overall subjective comfort2 weeks after contact lens wear

Subjective comfort rating on a scale of 0 (Painful) to 10 (Can't feel the lenses)

Secondary Outcome Measures
NameTimeMethod
Subjective visionVisit 2 and 3 - Approximately 1 and 2 weeks, respectively

Subjective vision rating on a scale of 0 (Not at all sharp/clear) to 10 (Sharp/Clear)

Overall subjective lens preferenceVisit 3 - After approximately 2 weeks of contact lens wear

Forced choice subjective preference for either lens type (1-Day ACUVUE® MOIST or Test DD contact lens) or no preference. i.e. three options presented and participant selects one option.

End of day subjective comfortVisit 2 and 3 - Approximately 1 and 2 weeks, respectively

Subjective comfort rating on a scale of 0 (Painful) to 10 (Can't feel the lenses)

Trial Locations

Locations (3)

Ross Eyecare

🇺🇸

Atlanta, Georgia, United States

Professional VisionCare

🇺🇸

Westerville, Ohio, United States

Primary Eyecare Group

🇺🇸

Brentwood, Tennessee, United States

Ross Eyecare
🇺🇸Atlanta, Georgia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.